Lsv Asset Management Eagle Pharmaceuticals, Inc. Transaction History

Lsv Asset Management

$46.7 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$3.34 - $5.6 $129,491 - $217,112	-38,770 Reduced 11.6%	295,388 $1.65 Million
Q1 2024 May 06, 2024	SELL	$4.26 - $6.51 $245,376 - $374,976	-57,600 Reduced 14.7%	334,158 $1.75 Million
Q4 2023 Feb 06, 2024	SELL	$4.63 - $15.21 $78,710 - $258,570	-17,000 Reduced 4.16%	391,758 $2.05 Million
Q2 2023 Aug 02, 2023	BUY	$17.74 - $31.87 $2.93 Million - $5.26 Million	165,022 Added 67.71%	408,758 $7.95 Million
Q1 2023 May 02, 2023	BUY	$25.06 - $34.09 $2.31 Million - $3.15 Million	92,318 Added 60.97%	243,736 $6.92 Million
Q4 2022 Feb 08, 2023	BUY	$24.98 - $39.77 $3.78 Million - $6.02 Million	151,418 New	151,418 $4.43 Million
Q1 2021 Apr 30, 2021	SELL	$40.32 - $50.97 $132,612 - $167,640	-3,289 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$41.72 - $51.34 $438,518 - $539,634	-10,511 Reduced 76.17%	3,289 $153,000
Q3 2020 Oct 23, 2020	SELL	$37.02 - $51.28 $5.73 Million - $7.93 Million	-154,701 Reduced 91.81%	13,800 $586,000
Q2 2020 Aug 05, 2020	SELL	$43.24 - $55.02 $6.56 Million - $8.35 Million	-151,726 Reduced 47.38%	168,501 $8.08 Million
Q1 2020 May 07, 2020	SELL	$34.37 - $60.07 $1.68 Million - $2.94 Million	-48,950 Reduced 13.26%	320,227 $14.7 Million
Q4 2019 Feb 10, 2020	SELL	$54.32 - $64.31 $5.02 Million - $5.94 Million	-92,381 Reduced 20.02%	369,177 $22.2 Million
Q3 2019 Nov 07, 2019	BUY	$53.25 - $59.98 $3.05 Million - $3.43 Million	57,189 Added 14.14%	461,558 $26.1 Million
Q2 2019 Aug 08, 2019	BUY	$46.61 - $58.45 $7.19 Million - $9.02 Million	154,365 Added 61.75%	404,369 $22.5 Million
Q1 2019 May 07, 2019	BUY	$38.66 - $51.82 $6.45 Million - $8.64 Million	166,715 Added 200.16%	250,004 $12.6 Million
Q4 2018 Feb 05, 2019	SELL	$36.72 - $67.73 $222,229 - $409,901	-6,052 Reduced 6.77%	83,289 $3.36 Million
Q3 2018 Nov 06, 2018	SELL	$66.65 - $83.86 $33.5 Million - $42.2 Million	-503,301 Reduced 84.92%	89,341 $6.19 Million
Q2 2018 Aug 08, 2018	SELL	$51.25 - $76.62 $13.7 Million - $20.4 Million	-266,500 Reduced 31.02%	592,642 $44.8 Million
Q1 2018 May 04, 2018	BUY	$52.16 - $66.86 $6.54 Million - $8.38 Million	125,320 Added 17.08%	859,142 $45.3 Million
Q4 2017 Feb 01, 2018	BUY	$49.6 - $60.87 $25.1 Million - $30.8 Million	506,028 Added 222.14%	733,822 $0
Q3 2017 Nov 13, 2017	BUY	$46.62 - $60.36 $10.6 Million - $13.7 Million	227,794	227,794 $13.6 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account